Morfeus ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  1.9% 2.5% 2.8% 2.1% 1.8%  
Credit score (0-100)  70 61 59 66 71  
Credit rating  A BBB BBB A A  
Credit limit (kDKK)  1.4 0.0 0.0 0.5 2.9  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  1,287 633 1,166 1,176 344  
EBITDA  641 -28.2 494 479 -383  
EBIT  641 -28.2 494 479 -383  
Pre-tax profit (PTP)  1,308.4 447.0 30.9 1,474.7 892.7  
Net earnings  1,020.1 348.8 24.1 1,148.3 695.5  
Pre-tax profit without non-rec. items  1,308 447 30.9 1,475 893  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  4,727 5,044 5,040 6,094 6,790  
Interest-bearing liabilities  4.9 6.7 6.6 6.7 7.1  
Balance sheet total (assets)  5,008 5,104 5,235 6,415 6,938  

Net Debt  -1,730 -1,795 -2,097 -159 -167  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,287 633 1,166 1,176 344  
Gross profit growth  16.0% -50.8% 84.2% 0.9% -70.8%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  5,008 5,104 5,235 6,415 6,938  
Balance sheet change%  24.9% 1.9% 2.6% 22.6% 8.1%  
Added value  640.9 -28.2 493.6 479.4 -382.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  5.0 -1.0 1.0 2.0 -1.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  49.8% -4.4% 42.3% 40.8% -111.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  29.4% 9.2% 11.5% 25.4% 13.4%  
ROI %  31.3% 9.5% 11.8% 26.6% 13.9%  
ROE %  24.1% 7.1% 0.5% 20.6% 10.8%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  94.4% 98.8% 96.3% 95.0% 97.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -269.9% 6,373.6% -424.9% -33.2% 43.6%  
Gearing %  0.1% 0.1% 0.1% 0.1% 0.1%  
Net interest  0 0 0 0 0  
Financing costs %  347.8% 310.2% 8,513.2% 115.1% 26.4%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  7.7 30.4 12.8 1.4 3.4  
Current Ratio  7.7 30.4 12.8 1.4 3.4  
Cash and cash equivalent  1,734.9 1,801.8 2,103.8 165.8 173.9  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  1,871.6 1,764.7 2,308.8 140.1 356.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  641 -28 494 479 -383  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  641 -28 494 479 -383  
EBIT / employee  641 -28 494 479 -383  
Net earnings / employee  1,020 349 24 1,148 696